ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Wyost 120 mg/ 1.7 ml, Injektionslösung - 
69944001 Sandoz Pharmaceuticals AG
Wyost 120 mg/ 1.7 ml, Injektionslösung24.01.2025
  24.01.2025
Denosumab (M05BX04) 
WHO-DDD23.01.2030
07.16.10. 
07.16.10. 
A  
Yes 
IP 
172.04Yes
    
10 %210.45
7680699440016Biotechnologika
  
Composition
denosumabum 120 mg, sorbitolum 78.9 mg, acidum aceticum glaciale, polysorbatum 20, natrii hydroxidum aut acidum hydrochloridum concentratum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml corresp. natrium 0.5 mg.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Denosumabum120 mg
BAG: Active AgentDose
Denosumabum120 mg
 
Inactive agentsDose
Acidum Aceticum Glaciale 
Natrii Hydroxidum aut Acidum Hydrochloridum Concentratum 
Polysorbatum 20 
Sorbitol78.9 mg
 
Source
Data was imported : 09.01.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home